194 related articles for article (PubMed ID: 28454298)
1. Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.
Chen X; Wang L; Liu J; Huang L; Yang L; Gao Q; Shi X; Li J; Li F; Zhang Z; Zhao S; Zhang B; Van der Bruggen P; Zhang Y
Oncol Lett; 2017 Mar; 13(3):1609-1618. PubMed ID: 28454298
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
5. Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study.
Sienel W; Varwerk C; Linder A; Kaiser D; Teschner M; Delire M; Stamatis G; Passlick B
Eur J Cardiothorac Surg; 2004 Jan; 25(1):131-4. PubMed ID: 14690745
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of melanoma antigen gene A3 expression in drug resistance of epidermal growth factor receptor-tyrosine kinase inhibitors in advanced nonsmall cell lung cancer treatment.
Jin J; Liu BZ; Wu ZM
J Cancer Res Ther; 2015 Nov; 11 Suppl():C271-4. PubMed ID: 26612451
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
Pan SH; Su KY; Spiessens B; Kusuma N; Delahaye NF; Gruselle O; Myo A; de Creus A; Louahed J; Chang GC; Yu SL; Yang PC
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e212-e223. PubMed ID: 27519286
[TBL] [Abstract][Full Text] [Related]
8. [Expression of melanoma-associated antigen-C2 in breast cancers and mechanism].
Li N; Hou R; Zhao LM; Gu G; Hou SY
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):821-826. PubMed ID: 34407585
[No Abstract] [Full Text] [Related]
9. Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC).
Yang XN; Huang L; Chen Y; An SJ; Zhang XC; Liao RQ; Su J; Wu YL
Chin J Cancer Res; 2015 Jun; 27(3):301-8. PubMed ID: 26157327
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
11. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
12. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
13. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
14. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
Ulloa-Montoya F; Louahed J; Dizier B; Gruselle O; Spiessens B; Lehmann FF; Suciu S; Kruit WH; Eggermont AM; Vansteenkiste J; Brichard VG
J Clin Oncol; 2013 Jul; 31(19):2388-95. PubMed ID: 23715562
[TBL] [Abstract][Full Text] [Related]
15. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
16. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
[TBL] [Abstract][Full Text] [Related]
17. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
Vansteenkiste J; Zielinski M; Linder A; Dahabreh J; Gonzalez EE; Malinowski W; Lopez-Brea M; Vanakesa T; Jassem J; Kalofonos H; Perdeus J; Bonnet R; Basko J; Janilionis R; Passlick B; Treasure T; Gillet M; Lehmann FF; Brichard VG
J Clin Oncol; 2013 Jul; 31(19):2396-403. PubMed ID: 23715567
[TBL] [Abstract][Full Text] [Related]
19. Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.
Zhao Q; Xu WT; Shalieer T
Dis Markers; 2016; 2016():2325987. PubMed ID: 27843173
[No Abstract] [Full Text] [Related]
20. The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma.
Guo L; Sang M; Liu Q; Fan X; Zhang X; Shan B
Oncol Lett; 2013 Jul; 6(1):55-62. PubMed ID: 23946777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
